Centinel Spine announces Steven F Murray as CEO

4171
Steven F Murray

Centinel Spine has announced Steven F Murray as CEO, effective March 16, 2020, succeeding the current chairman and CEO John J Viscogliosi.

“As a founder, chairman and CEO of Centinel Spine over a decade ago through the merger and acquisition of two pioneering medical device companies—Raymedica, LLC and Surgicraft, LTD, I am proud of the more than 200,000 patients who have been helped by our various technology platforms,” said Viscogliosi. “The foundation has been laid for continued success and Steven is the right leader to take the company forward. I would like to thank all of those who have worked tirelessly alongside me to bring Centinel to this point. I am proud to have been able to work side by side with you.”

Steven F Murray was most recently president of advanced sterilization products at Johnson & Johnson, and has over 25 years of experience in orthopaedics and 20 years as an executive. Murray received his MBA from Tuck School of Business at Dartmouth College (Hanover, USA) before moving on to leadership positions including president of Synthes Craniomaxillofacial, president of Synthes Spine and worldwide president of the neuro companies of DePuy Synthes at Johnson & Johnson.

“Centinel Spine is an impressive company that I have long respected, and I am pleased to be joining the team at this exciting time. John J Viscogliosi has built the largest privately held spine company focused on anterior column reconstruction backed by over 30 years of clinical success. Building on this excellent foundation—we will continue to transform patients’ lives with our cutting-edge technology and innovative patient education platforms,” said Murray.


LEAVE A REPLY

Please enter your comment!
Please enter your name here